Cargando…

High Expression of Solute Carrier Family 2 Member 1 (SLC2A1) in Cancer Cells Is an Independent Unfavorable Prognostic Factor in Pediatric Malignant Peripheral Nerve Sheath Tumor

Malignant peripheral nerve sheath tumor (MPNST) in children is a rare mesenchymal malignancy developing predominantly in the setting of neurofibromatosis type 1. The prognosis in advanced MPNST is poor therefore new prognostic markers are highly needed for optimal therapeutic decisions. In many soli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krawczyk, Malgorzata A., Kunc, Michal, Styczewska, Malgorzata, Gabrych, Anna, Karpinsky, Gabrielle, Izycka-Swieszewska, Ewa, Bien, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065586/ https://www.ncbi.nlm.nih.gov/pubmed/33810575 http://dx.doi.org/10.3390/diagnostics11040598

Ejemplares similares

Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor
por: Karpinsky, Gabrielle, et al.
Publicado: (2018)

Bilateral Ovarian Germ Cell Tumor in a 46,XX Female with Nijmegen Breakage Syndrome and Hypergonadotropic Hypogonadism
por: Krawczyk, Malgorzata A., et al.
Publicado: (2022)

The Role of Chemotherapy in Management of Inoperable, Metastatic and/or Recurrent Melanotic Neuroectodermal Tumor of Infancy—Own Experience and Systematic Review
por: Styczewska, Małgorzata, et al.
Publicado: (2021)

Systemic inflammatory markers and serum lactate dehydrogenase predict survival in patients with Wilms tumour
por: Kunc, Michał, et al.
Publicado: (2021)

Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases
por: Bien, Ewa, et al.
Publicado: (2010)

Hypoxic hepatitis as a complication of newly diagnosed type 1 diabetes in a teenager
por: Buczkowski, Kamil, et al.
Publicado: (2022)

Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data
por: Sigorski, Dawid, et al.
Publicado: (2020)

Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma
por: Zhang, Qinglin, et al.
Publicado: (2021)

Upregulated Solute Carrier SLC39A1 Promotes Gastric Cancer Proliferation and Indicates Unfavorable Prognosis
por: Yu, Dan, et al.
Publicado: (2022)

Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study
por: Izycka-Swieszewska, Ewa, et al.
Publicado: (2018)

Investigation of Neural Microenvironment in Prostate Cancer in Context of Neural Density, Perineural Invasion, and Neuroendocrine Profile of Tumors
por: Sigorski, Dawid, et al.
Publicado: (2021)

An Unfavorable Outcome of M. chimaera Infection in Patient with Silicosis
por: Łyżwa, Ewa, et al.
Publicado: (2022)

Association of Hepcidin mRNA Expression With Hepatocyte Iron Accumulation and Effects of Antiviral Therapy in Chronic Hepatitis C Infection
por: Sikorska, Katarzyna, et al.
Publicado: (2014)

Primary Spinal Intradural Mesenchymal Chondrosarcoma with Several Local Regrowths Treated with Osteoplastic Laminotomies: A Case Report
por: Derenda, Marek, et al.
Publicado: (2017)

Expression of BARD1 β Isoform in Selected Pediatric Tumors
por: Jasiak, Anna, et al.
Publicado: (2021)

Sympathetic nervous signaling dictates prostate cancer progression
por: Sigorski, D., et al.
Publicado: (2022)

Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study
por: Nowicki, Tomasz K., et al.
Publicado: (2018)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
por: Izycka, Natalia, et al.
Publicado: (2023)

microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study
por: Kunc, Michał, et al.
Publicado: (2020)

The human solute carrier family 11 member 1 protein (SLC11A1): linking infections, autoimmunity and cancer?
por: Awomoyi, Agnes A
Publicado: (2007)

Paraneoplastic syndromes in olfactory neuroblastoma
por: Kunc, Michał, et al.
Publicado: (2015)

Dysgerminoma with a Somatic Exon 17 KIT Mutation and SHH Pathway Activation in a Girl with Turner Syndrome
por: Gawrychowska, Ada, et al.
Publicado: (2020)

Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread
por: Sigorski, Dawid, et al.
Publicado: (2022)

c.1810C>T Polymorphism of NTRK1 Gene is associated with reduced Survival in Neuroblastoma Patients
por: Lipska, Beata S, et al.
Publicado: (2009)

Is hepatotropic contrast enhanced MR a more effective method in differential diagnosis of hemangioma than multi-phase CT and unenhanced MR?
por: Szurowska, Edyta, et al.
Publicado: (2011)

On the significance of germline cytogenetic rearrangements at MYCN locus in neuroblastoma
por: Lipska, Beata S, et al.
Publicado: (2013)

Solute Carrier Family 37 Member 2 (SLC37A2) Negatively Regulates Murine Macrophage Inflammation by Controlling Glycolysis
por: Wang, Zhan, et al.
Publicado: (2020)

A missense mutation in solute carrier family 12, member 1 (SLC12A1) causes hydrallantois in Japanese Black cattle
por: Sasaki, Shinji, et al.
Publicado: (2016)

MLH1 promoter hypermethylation in uterine carcinosarcoma rarely coexists with TP53 mutation
por: Kunc, Michal, et al.
Publicado: (2019)

Solute Carrier Family 26 Member a2 (slc26a2) Regulates Otic Development and Hair Cell Survival in Zebrafish
por: Liu, Fei, et al.
Publicado: (2015)

Integrated analysis of Solute carrier family-2 members reveals SLC2A4 as an independent favorable prognostic biomarker for breast cancer
por: Shi, Zhenyu, et al.
Publicado: (2021)

Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 “SLC34A2” in Papillary Thyroid Carcinoma: An Immunohistochemical Study
por: Hakim, Sarah Adel, et al.
Publicado: (2021)

Comparative genomic analysis of intracranial germ cell tumors – the preliminary study focused on Sonic Hedgehog signaling pathway
por: Kuleszo, Dominika, et al.
Publicado: (2017)

Case Report: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Application in Intraperitoneally Disseminated Inflammatory Myofibroblastic Tumor and in the Youngest Patient in the World: New Indication and Modification of Technique
por: Garnier, Hanna, et al.
Publicado: (2021)

Association Study of the SLC1A2 (rs4354668), SLC6A9 (rs2486001), and SLC6A5 (rs2000959) Polymorphisms in Major Depressive Disorder
por: Rodek, Patryk, et al.
Publicado: (2022)

Welcome to the Family: Identification of the NAD(+) Transporter of Animal Mitochondria as Member of the Solute Carrier Family SLC25
por: Ziegler, Mathias, et al.
Publicado: (2021)

Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target
por: Sun, Ming, et al.
Publicado: (2017)

Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma
por: Huang, Zigao, et al.
Publicado: (2023)

High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma
por: Liu, Yidong, et al.
Publicado: (2015)

Exploring Extracellular Vesicles of Probiotic Yeast as Carriers of Biologically Active Molecules Transferred to Human Intestinal Cells
por: Mierzejewska, Jolanta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_51o41monoavri9epik8uoub55g